Article Details

New Data Reinforce Long-Term Benefit of Emicizumab for Patients With Hemophilia A

Retrieved on: 2020-12-11 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

New Data Reinforce Long-Term Benefit of Emicizumab for Patients With Hemophilia A. View article details on hiswai:

Excerpt

According to <b>Roche</b>, the disorder affects approximately 320,000 people worldwide. “The long-term benefit of [emicizumab], with a consistent safety ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo